outcome

Improving Patient Outcomes through the Diagnostic and Care Planning Process




outcome

The noninvasive ventilation outcomes score in patients requiring NIV for COPD exacerbation without prior evidence of airflow obstruction

Introduction

Exacerbation of COPD complicated by respiratory acidaemia is the commonest indication for noninvasive ventilation (NIV). The NIV outcomes (NIVO) score offers the best estimate of survival for those ventilated. Unfortunately, two-thirds of cases of COPD are unrecognised, and patients may present without COPD having been confirmed by spirometry.

Methods

In the 10-centre NIVO validation study there was no pre-admission spirometry in 111 of 844 consecutive patients (termed "clinical diagnosis" patients). We compared the performance of the NIVO, DECAF and CURB-65 scores for in-hospital mortality in the clinical diagnosis cohort. Usual clinical practice was not influenced, but confirmation of COPD in the year following discharge was captured.

Results

In the clinical diagnosis cohort, in-hospital mortality was 19.8% and rose incrementally across the NIVO risk categories, consistent with the NIVO validation cohort. NIVO showed good discrimination in the clinical diagnosis cohort: area under the receiver operating curve 0.724, versus 0.79 in the NIVO validation cohort. At 1 year after discharge, 41 of 89 clinical diagnosis patients had undertaken diagnostic spirometry; 33 of 41 had confirmation of airflow obstruction (forced expiratory volume in 1 s/(forced) vital capacity <0.7), meaning the diagnosis of COPD was incorrect in 19.5% of cases.

Discussion

These data support the use of the NIVO score in patients with a "clinical diagnosis" of COPD. NIVO can help guide shared decision-making, assess risk-adjusted outcomes by centre and challenge prognostic pessimism. Accurate diagnosis is critical to ensure that acute and long-term treatment is optimised; this study highlights failings in the follow-up of such patients.




outcome

Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction

[177Lu]Lu-PSMA-617 was approved by the U.S. Food and Drug Administration for patients with prostate-specific membrane antigen (PSMA)–positive metastatic castration-resistant prostate cancer (mCRPC). Since the time of regulatory approval, however, real-world data have been lacking. This study investigated the efficacy, safety, and outcome predictors of [177Lu]Lu-PSMA-617 at a major U.S. academic center. Methods: Patients with mCRPC who received [177Lu]Lu-PSMA-617 at the Johns Hopkins Hospital outside clinical trials were screened for inclusion. Patients who underwent [177Lu]Lu-PSMA-617 and had available outcome data were included in this study. Outcome data included prostate-specific antigen (PSA) response (≥50% decline), PSA progression-free survival (PFS), and overall survival (OS). Toxicity data were evaluated according to the Common Terminology Criteria for Adverse Events version 5.03. The study tested the association of baseline circulating tumor DNA mutational status in homologous recombination repair, PI3K alteration pathway, and aggressive-variant prostate cancer–associated genes with treatment outcome. Baseline PSMA PET/CT images were analyzed using SelectPSMA, an artificial intelligence algorithm, to predict treatment outcome. Associations with the observed treatment outcome were evaluated. Results: All 76 patients with PSMA-positive mCRPC who received [177Lu]Lu-PSMA-617 met the inclusion criteria. A PSA response was achieved in 30 of 74 (41%) patients. The median PSA PFS was 4.1 mo (95% CI, 2.0–6.2 mo), and the median OS was 13.7 mo (95% CI, 11.3–16.1 mo). Anemia of grade 3 or greater, thrombocytopenia, and neutropenia were observed in 9 (12%), 3 (4%), and 1 (1%), respectively, of 76 patients. Transient xerostomia was observed in 23 (28%) patients. The presence of aggressive-variant prostate cancer–associated genes was associated with a shorter PSA PFS (median, 1.3 vs. 6.3 mo; P = 0.040). No other associations were observed between circulating tumor DNA mutational status and treatment outcomes. Eighteen of 71 (25%) patients classified by SelectPSMA as nonresponders had significantly lower rates of PSA response than patients classified as likely responders (6% vs. 51%; P < 0.001), a shorter PSA PFS (median, 1.3 vs. 6.3 mo; P < 0.001), and a shorter OS (median, 6.3 vs. 14.5 mo; P = 0.046). Conclusion: [177Lu]Lu-PSMA-617 offered in a real-world setting after regulatory approval in the United States demonstrated antitumor activity and a favorable toxicity profile. Artificial-intelligence–based analysis of baseline PSMA PET/CT images may improve patient selection. Validation of these findings on larger cohorts is warranted.




outcome

Predictors and Outcomes of Periprocedural Intracranial Hemorrhage after Stenting for Symptomatic Intracranial Atherosclerotic Stenosis [CLINICAL PRACTICE]

BACKGROUND AND PURPOSE:

Periprocedural intracranial hemorrhage is one of common complications after stent placement for symptomatic intracranial atherosclerotic stenosis. This study was conducted to demonstrate predictors and long-term outcomes of periprocedural intracranial hemorrhage after stent placement for symptomatic intracranial atherosclerotic stenosis.

MATERIALS AND METHODS:

We retrospectively analyzed patients with symptomatic intracranial atherosclerotic stenosis stent placement in a prospective cohort at a high-volume stroke center. Clinical, radiologic, and periprocedural characteristics and long-term outcomes were reviewed. Periprocedural intracranial hemorrhage was classified as procedure-related hemorrhage (PRH) and non-procedure-related hemorrhage (NPRH). The long-term outcomes were compared between patients with PRH and NPRH, and the predictors of NPRH were explored.

RESULTS:

Among 1849 patients, 24 (1.3%) had periprocedural intracranial hemorrhage, including PRH (4) and NPRH (20). The postprocedural 30-day mRS was 0–2 in 9 (37.5%) cases, 3–5 in 5 (20.8%) cases, and 6 in 10 (41.7%) cases. For the 14 survivors, the long-term (median of 78 months) mRS were 0–2 in 10 (76.9%) cases and 3–5 in 3 (23.1%) cases. The proportion of poor long-term outcomes (mRS ≥3) in patients with NPRH was significantly higher than those with PRH (68.4% versus 0%, P = .024). Anterior circulation (P = .002), high preprocedural stenosis rate (P < .001), and cerebral infarction within 30 days (P = .006) were independent predictors of NPRH after stent placement.

CONCLUSIONS:

Patients with NPRH had worse outcomes than those with PRH after stent placement for symptomatic ICAS. Anterior circulation, severe preprocedural stenosis, and recent infarction are independent predictors of NPRH.




outcome

Are federal IT systems supporting the targeted service outcomes? Deloitte examines the future role of the government

In an interview with IT World Canada, consulting giant Deloitte highlighted the importance of an ecosystem-based approach to tackle issues around digital equity in Canada and service delivery challenges in the public sector. “Our strong view is that the people of Canada benefit when there’s effective collaboration between public and private organizations, including on critical […]

The post Are federal IT systems supporting the targeted service outcomes? Deloitte examines the future role of the government first appeared on ITBusiness.ca.




outcome

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes

Today’s guest post comes from Kimberley Chiang, Vice President of Biopharma Commercial Solutions at CoverMyMeds

Kimberley highlghts the crucial roles of field reimbursement managers in removing access and reimbursement barriers. She then identifies the keys to successful implementation of field reimbursement services.

To learn more, register for CoverMyMeds' November 13, 2024, webinar: Specialty Therapies & Field Reimbursement Services: Driving Better Outcomes for Brands and Patients.

Read on for Kimberley’s insights.
Read more »
       




outcome

Medications for Opioid Use Disorder Improve Patient Outcomes

In 2018, opioid overdoses in the United States caused one death every 11 minutes, resulting in nearly 47,000 fatalities. The most effective treatments for opioid use disorder (OUD) are three medications approved by the Food and Drug Administration (FDA): methadone, buprenorphine, and naltrexone.




outcome

Examining the Outcomes of COP 28: A Conversation with Amy Harder

Amy Harder, the founding Executive Editor of the climate policy publication Cipher News, expressed her surprise with several positive outcomes from the recent 28th Conference of the Parties of the United Nations Framework Convention on Climate Change (COP 28) in Dubai during a special episode of “Environmental Insights: Discussions on Policy and Practice from the Harvard Environmental Economics Program.”





outcome

Exploring the Consistent Outcomes of an Antiviral Drug

Regardless of HIV status, medlinktecovirimat/medlink, an medlinkantiviral drug/medlink that has been extensively employed to treat medlinksmallpox/medlink




outcome

AI-Powered Nasal Endoscopy: Enhancing Precision and Outcomes

New study investigates how convolutional neural networks (CNNs) can enhance nasal endoscopy accuracy and efficiency. The study focuses on overcoming diagnostic




outcome

Mobile Health Apps Linked to Improved Health and Economic Outcomes

Study finds that diabetic Asian patients that used smart mobile health (or mHealth) technologies had better health and economic outcomes than those who didn't use mHealth applications.




outcome

Prehabilitation: Preparing Patients for Surgery Boosts Outcomes

'Prehabilitation' meaning pre-surgery exercise and education is associated with improving some outcomes for patients undergoing medlinkorthopedic surgery/medlink




outcome

Medicaid Improves Cancer Survival Outcomes in the US

Among young adults aged 18-39 newly diagnosed with cancer, the expanded Medicaid coverage under the Affordable Care Act (ACA) led to better survival outcomes,




outcome

Medicaid Expansion and Pregnancy Outcomes in Gestational Diabetes

The Affordable Care Act (ACA) seeks to enhance healthcare accessibility, yet its impact on maternal and newborn health in women with medlinkgestational




outcome

Chasing the most meaningful outcome of entrepreneurship

Are there any metrics to decide if a founder is successful or not?




outcome

Functional silver-based nanomaterials affecting zebrafish development: the adverse outcomes in relation to the nanoparticle physical and chemical structure

Environ. Sci.: Nano, 2024, Accepted Manuscript
DOI: 10.1039/D3EN00813D, Paper
Open Access
Patrizia Bonfanti, Anita Colombo, Rossella Daniela Bengalli, Maurizio Gualtieri, Ilaria Zanoni, Magda Blosi, Anna Costa, Paride Mantecca
The growing demand for effective antimicrobials determined a significant increase of new nanoformulated materials to fight against bacteria and viruses, to be used in many industrial sectors including textiles, cosmetics,...
The content of this RSS Feed (c) The Royal Society of Chemistry




outcome

Empowering Pharma with AI, Analytics: Accelerating Drug Discovery, Optimizing Healthcare Outcomes By Rajesh Munirathnam

While AI is making significant strides in healthcare, it is also transforming other industries, such as insurance.




outcome

Dewan Housing Finance Corporation Ltd. - Outcome Of The Meeting Of The Special Committee For Resolution Plan Held On Tuesday, 6Th August, 2019 And Disclosures Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosur




outcome

Dewan Housing Finance Corpn Ltd, - Outcome Of The Meeting Of The Special Committee For Resolution Plan Held On Tuesday, 6Th August, 2019 And Disclosures Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requ




outcome

The remarkable surge of interest in plotted developments is an outcome of the pandemic

High- and ultra-high-net-worth individuals are increasingly investing in weekend homes or private villas, built in the peripheries of cities



  • Homes and gardens

outcome

Women's Empowerment, the Gender Gap in Desired Fertility, and Fertility Outcomes in Developing Countries [electronic journal].




outcome

Wealth Shocks and Health Outcomes: Evidence from Stock Market Fluctuations [electronic journal].




outcome

Robot Imports and Firm-Level Outcomes [electronic journal].




outcome

Randomizing Religion: The Impact of Protestant Evangelism on Economic Outcomes [electronic journal].

National Bureau of Economic Research




outcome

Poor Little Rich Kids? The Role of Nature versus Nurture in Wealth and Other Economic Outcomes and Behaviors [electronic journal].

National Bureau of Economic Research




outcome

Police Response Times and Injury Outcomes [electronic journal].




outcome

The Lost Ones: the Opportunities and Outcomes of Non-College Educated Americans Born in the 1960s [electronic journal].

National Bureau of Economic Research




outcome

Lift the Ban? Initial Employment Restrictions and Refugee Labour Market Outcomes [electronic journal].




outcome

The Lasting Legacy of Seasonal Influenza: In-Utero Exposure and Labor Market Outcomes [electronic journal].




outcome

Intersectoral linkages: Good shocks, bad outcomes? [electronic journal].




outcome

The Importance of Beliefs in Shaping Macroeconomic Outcomes [electronic journal].

National Bureau of Economic Research




outcome

Impact of Syrian Refugees on Education Outcomes in Jordan [electronic journal].




outcome

The Human Side of Austerity: Health Spending and Outcomes During the Greek Crisis [electronic journal].

National Bureau of Economic Research




outcome

Field of study and family outcomes [electronic journal].




outcome

Experimental Evidence of Exposure to a Conditional Cash Transfer During Early Teenage Years: Young Women's Fertility and Labor Market Outcomes [electronic journal].




outcome

The Economic Outcomes of an Ethnic Minority: the Role of Barriers [electronic journal].




outcome

Does pre-play social interaction improve negotiation outcomes? [electronic journal].




outcome

Do Preferences and Biases predict Life Outcomes? Evidence from Education and Labor Market Entry Decisions [electronic journal].




outcome

Can Credit Rating Agencies Affect Election Outcomes? [electronic journal].




outcome

Carnatic music export: Positive outcomes and areas of concern

The increasing Carnatic music festivals abroad show the growing interest of the NRIs, and a huge financial market for the art form




outcome

Haryana — social dynamics, electoral outcomes

The recent Assembly polls are an example of how changing social dynamics impact the election result




outcome

Redesigned programmes can vastly improve TB treatment outcomes

Doubling the direct benefit transfer to Rs.1,000 per month, disbursing Rs.3,000 at the time of diagnosis, and nutrition support to TB patients can have a huge impact




outcome

Tinna Trade Ltd - Outcome Of Board Meeting And Unaudited Financial Results Of The Company For The Quarter Ended On 30Th June, 2019, As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015




outcome

Lok Sabha 2024 poll verdict: a rare outcome that pleases all




outcome

Birla Cable Ltd - Shareholder Meeting / Postal Ballot-Outcome of AGM




outcome

Icici Securities Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome




outcome

Keerthi Industries Ltd. - Shareholder Meeting / Postal Ballot-Outcome of AGM




outcome

Aarti Drugs Ltd. - Shareholder Meeting / Postal Ballot-Outcome of AGM




outcome

Simplex Realty Ltd. - Outcome of Board Meeting